IDH1 and central nervous system cancer: In a recent meta-analysis about T2-FLAIR mismatch sign among adult patients with low-grade glioma, the pooled specificity of T2-FLAIR mismatch sign for astrocytoma, IDH-mutant was 99% (95% CI: 96–100%) [8].